These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 355012)

  • 21. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serovaccination by human immune globulin and HDCS-vaccine against rabies.
    Kuwert EK; Werner J; Marcus I; Cabasso VJ
    Dev Biol Stand; 1978; 40():129-36. PubMed ID: 680386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the inactivated tissue culture rabies vaccine from the Vnukovo-32 strain. Results of its industrial production and field use for post-exposure immunization of man.
    Selimov M; Aksenova T; Klyueva E; Gribencha L; Lebedeva I
    Dev Biol Stand; 1978; 40():57-62. PubMed ID: 680402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of aluminum adjuvant to experimental rabies vaccine].
    Lin H; Perrin P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):133-5. PubMed ID: 12569779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on candidate reference preparations of rabies vaccine.
    Wiktor TJ; Boegel K; Cox JH; Diaz AM; Fitzgerald E; Netter R; Turner G; Schneider LG; van Steenis G
    Dev Biol Stand; 1978; 40():187-93. PubMed ID: 355014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of cellular and humoral immune responses after immunization with different rabies vaccines.
    Pille ER; Vagabov MA; Karakuyumchan MK; Matevosyan KS
    Acta Virol; 1985 Mar; 29(2):137-42. PubMed ID: 2860797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preventive rabies vaccination using vaccine prepared from human diploid cells].
    Costy-Berger F
    Dev Biol Stand; 1978; 40():101-4. PubMed ID: 680381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of methods for controlling the immunogenicity of rabies vaccines].
    Dilovski M; Antonov P
    Vet Med Nauki; 1982; 19(7):66-72. PubMed ID: 6760532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine.
    Cox JH; Klietmann W; Schneider LG
    Dev Biol Stand; 1978; 40():105-8. PubMed ID: 680382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response in primates vaccinated with duck embryo cell culture rabies vaccine.
    Lavender JF
    Appl Microbiol; 1973 Mar; 25(3):327-31. PubMed ID: 4633422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.